The GLP-1 receptor agonists reduce appetite and greatly facilitate weight loss. Robert Kushner, MD, of Northwestern University Feinberg School of Medicine joins JAMA Deputy Editor Mary M. McDermott, MD, to discuss appropriate diet and exercise recommendations for patients receiving GLP-1 receptor agonists for weight loss.

Related Content:

• Lifestyle Modification and Incretin-Based Therapy for Obesity
• The Conundrum of Exercise for Weight Management in the GLP-1 Receptor Agonist Era